Hypatia Launches Bento Bio, Putting Patients at The Center of Clinical Trials

Written By Guest User

Hypatia, an engineering firm with distinguished history building AI software factories and consortium blockchains for governments and the Fortune 500, is launching Bento Bio, a clinical trial platform technology that addresses the need for more remote clinical trials and increased patient retention and allows patients to take ownership of and monetize their own data.

Read the full press release here.

Guest User
Previous

Bento’s Chief Operations & Health Equity Officer Speaks to Students at APTA’s Combined Sections Meeting
Next

Bento Bio: From Data Donorship to Data Ownership - Part 1: The Vision